Literature DB >> 8095266

The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter.

H L Pahl1, R J Scheibe, D E Zhang, H M Chen, D L Galson, R A Maki, D G Tenen.   

Abstract

The myeloid integrin CD11b is expressed selectively on the surface of mature monocytes, macrophages, granulocytes, and natural killer cells. Tissue-specific and developmentally regulated expression of CD11b is controlled at the level of mRNA transcription, and recent characterization of the human CD11b promoter indicates that the first 92 bp of 5'-flanking DNA are sufficient to direct tissue-specific expression of a reporter gene. Here we show that the sequence AAAAGGAGAAG at base pair -20 of the CD11b promoter binds the proto-oncogene PU.1 in vitro and that mutation of this site significantly reduces the ability of the CD11b promoter to direct expression of a reporter gene in myeloid cells but not in nonmyeloid cells. PU.1 may thus represent a major determinant of the myeloid expression of CD11b.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095266

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  79 in total

1.  Mutants of ETS domain PU.1 and GGAA/T recognition: free energies and kinetics.

Authors:  F Pio; N Assa-Munt; J Yguerabide; R A Maki
Journal:  Protein Sci       Date:  1999-10       Impact factor: 6.725

2.  Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1.

Authors:  Jynho Kim; Ricardo A Feldman
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

3.  Cytokine and integrin stimulation synergize to promote higher levels of GATA-2, c-myb, and CD34 protein in primary human hematopoietic progenitors from bone marrow.

Authors:  Mo A Dao; Jan A Nolta
Journal:  Blood       Date:  2006-11-09       Impact factor: 22.113

4.  The conserved 5'-untranslated leader of Spi-1 (PU.1) mRNA is highly structured and potently inhibits translation in vitro but not in vivo.

Authors:  J O Hensold; C A Stratton; D Barth
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

5.  Regulation of keratin and integrin gene expression in cancer and drug resistance.

Authors:  N Daly; P Meleady; D Walsh; M Clynes
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

Review 6.  IL-32θ: a recently identified anti-inflammatory variant of IL-32 and its preventive role in various disorders and tumor suppressor activity.

Authors:  Muhammad Babar Khawar; Maryam Mukhtar; Muddasir Hassan Abbasi; Nadeem Sheikh
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

7.  Involvement of the transcription factor PU.1/Spi-1 in myeloid cell-restricted expression of an interferon-inducible gene encoding the human high-affinity Fc gamma receptor.

Authors:  C Perez; E Coeffier; F Moreau-Gachelin; J Wietzerbin; P D Benech
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

8.  PU.1 directly regulates cdk6 gene expression, linking the cell proliferation and differentiation programs in erythroid cells.

Authors:  Kevin S Choe; Olga Ujhelly; Sandeep N Wontakal; Arthur I Skoultchi
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

9.  SIRT1 inhibits differentiation of monocytes to macrophages: amelioration of synovial inflammation in rheumatoid arthritis.

Authors:  So Youn Park; Sung Won Lee; Hye Young Kim; Sang Yeob Lee; Won Suk Lee; Ki Whan Hong; Chi Dae Kim
Journal:  J Mol Med (Berl)       Date:  2016-03-09       Impact factor: 4.599

10.  Sp1 binds two sites in the CD11c promoter in vivo specifically in myeloid cells and cooperates with AP1 to activate transcription.

Authors:  J D Noti; B C Reinemann; M N Petrus
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.